Skip to content
With a growing population comes increased demand for food and produce. And from natural fertilizers such as ground bones and manure to human-made and […]
The plant biostimulant market is set to boom Read More »
On August 4, U.S. lawmakers introduced two new bills in an effort to further strengthen the Vaccine Injury Compensation Program (VICP) and help the
House introduces bills to strengthen Vaccine Injury Compensation Program (VICP) Read More »
Photo: BIO’s Emily Wheeler (second from left) with Jean Mwale, Amputee Coalition regional ambassador and sepsis survivor (right), at the Amputee Coalition 2023 National
How amputees give voice to AMR Read More »
The Centers for Disease Control and Prevention (CDC) added a recently approved monoclonal antibody (mAb) for respiratory syncytial virus (RSV) prevention to the list
CDC recommends routine use of RSV monoclonal antibody for infants Read More »
The World Health Organization (WHO) reports that routine vaccination rates among children have increased, although there’s room for improvement. According to UNICEF and WHO
Routine immunization among kids is improving Read More »
Voters hold a favorable opinion of biotechnology and support streamlined government regulatory processes to allow faster approval of biotech innovations in agriculture, according to
A new antibiotic that could potentially be effective against many superbugs, tuberculosis, and even “untreatable” illnesses has been discovered, reports Nature, using none other
From AI to antibiotics: Can machine learning help us fight superbugs? Read More »
The 340B Program has grown exponentially as hospitals take advantage of the opportunity to profit from drug discounts while the low-income and uninsured patients
BIO tells Senators the 340B program needs reforms so it helps patients Read More »
International partnerships are vital to delivering new biotech solutions for the health of people and the planet—and strong policies, both in the U.S. and
BIO Asia-Taiwan 2023 highlights importance of cross-border collaboration Read More »
Federal support empowers a public-private partnership that helps ensure U.S. leadership in drug development—and the relationship should not be changed by calls for arbitrary
BIO expert lauds beautiful relationship between NIH and biotech Read More »
